Skip to main content

Table 2 Proportion of patients with asthma control (ACQ score ≤ 0.75)

From: Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study

Asthma control

4 weeks

12 weeks

n

%

n

%

Montelukast monotherapy

All patients, n (%)

(N = 75)

(N = 68)

   Well controlled

46

61.3

51

75.0

   Not controlled

29

38.7

17

25.0

Preschool aged patients, n (%)

(N = 34)

(N =32 )

   Well controlled

19

55.9

24

75.0

   Not controlled

15

44.1

8

25.0

School aged patients, n (%)

(N =41 )

(N = 36)

   Well controlled

27

65.9

27

75.0

   Not controlled

14

34.1

9

25.0

Montelukast + ICS

All patients, n (%)

(N = 244)

(N = 220)

   Well controlled

129

52.9

156

70.9

   Not controlled

115

47.1

64

29.1

Preschool aged patients, n (%)

(N = 105)

(N = 96)

   Well controlled

69

65.7

75

78.1

   Not controlled

36

34.3

21

21.9

School aged patients, n (%)

(N = 139)

(N = 124)

   Well controlled

60

43.2

81

65.3

   Not controlled

79

56.8

43

34.7

Total study sample (Montelukast monotherapy & Montelukast + ICS)

All patients, n (%)

(N = 319)

(N = 288)

   Well controlled

175

54.9

207

71.9

   Not controlled

144

45.1

81

28.1

Preschool aged patients, n (%)

(N = 139)

(N = 128)

   Well controlled

88

63.3

99

77.3

   Not controlled

51

36.7

29

22.7

School aged patients, n (%)

(N = 180)

(N = 160)

   Well controlled

87

48.3

108

67.5

   Not controlled

93

51.7

52

32.5